(Q42814001)

7 November 2017

Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab'. (English)

1 reference

7 November 2017

1 reference

1 reference

F Bibeau

1

1 reference

7 November 2017

H Gil

series ordinal

2

1 reference

7 November 2017

F Castan

series ordinal

3

1 reference

7 November 2017

F Boissière-Michot

series ordinal

4

1 reference

7 November 2017

language of work or name

English

0 references

publication date

24 October 2013

1 reference

British Journal of Cancer

7 November 2017

1 reference

7 November 2017

109

1 reference

7 November 2017

12

1 reference

7 November 2017

3127-3129

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2013.651

7 November 2017

0 references

cites work

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859938

Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859938

Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859938

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859938

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859938

Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859938

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24157831

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24157831

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2013.651

1 reference

7 November 2017

1 reference

7 November 2017

1 reference